Rabe, Klaus F <br/><br/>
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.  [electronic resource] 

 -  The New England journal of medicine  06 2018 
 - 2475-2485 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa1804093  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adolescent<br/>Adult<br/>Anti-Asthmatic Agents--adverse effects<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Asthma--classification<br/>Child<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Eosinophilia--chemically induced<br/>Female<br/>Forced Expiratory Volume--drug effects<br/>Glucocorticoids--administration & dosage<br/>Humans<br/>Injections, Subcutaneous--adverse effects<br/>Intention to Treat Analysis<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Receptors, Interleukin-4--antagonists & inhibitors<br/>Young Adult